XXXX in an immunocompromised host.

@entity1 @entity3329 @entity1210 @entity1910 @entity4 @entity1066 @entity2711 @entity1431 @entity11102 @entity1499 @entity221 @entity309 @entity288
BACKGROUND: The main causative agents of @entity11102 are @entity2711 , tiny, gram-negative bacilli. The disease usually has a benign course with the development of a papule at the inoculation site, followed by regional @entity3329 . In most cases, complete resolution occurs, but in immunocompromised hosts, the course of the disease can be aggravated. CASE REPORT: A @entity1 received @entity1499 and @entity288 for 3 months due to @entity309 . He developed @entity221 , @entity1910 and @entity1431 under @entity1499 therapy. Dark red indurations with central @entity1066 at his right thigh revealed a further problem apart from the @entity1499 -induced @entity1210 and immunosuppression. The @entity1066 were the remainders of recurrent scratches from the @entity1 's cat. The patient's antibody titers against @entity2711 remained low and @entity4 was only for a short time to be observed, this reaction obviously weakened as a result of the immunosuppression. However, the typical course, the exclusion of other reasons for the @entity1910 and the rapid improvement of the @entity1 's condition after antibiotic treatment ascertained the diagnosis. CONCLUSIONS: In immunocompromised hosts, diseases with a typically benign course can become severe and life-threatening illnesses. Ownership of pets should be taken into consideration before onset of an immunosuppressive therapy.
